Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer.

Autor: Alkan A; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey.; Department of Medical Oncology, School of Medicine, Muğla Sıtkı Koçman University, Muğla, Turkey., Mızrak D; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Yaşar A; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Karcı E; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Köksoy EB; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Ürün M; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Özyurt N; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Kuştaş AA; Department of Internal Medicine, School of Medicine, Ankara University, Ankara, Turkey., Kütük T; Department of Radiation Oncology, School of Medicine, Ankara University, Ankara, Turkey., Ürün Y; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Şenler FÇ; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Akyürek S; Department of Radiation Oncology, School of Medicine, Ankara University, Ankara, Turkey., Utkan G; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Demirkazık A; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey., Gökçe ŞÇ; Department of Radiation Oncology, School of Medicine, Ankara University, Ankara, Turkey., Akbulut H; Department of Medical Oncology, School of Medicine, Ankara University, Ankara, Turkey.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2024 Apr 01; Vol. 20 (3), pp. 913-917. Date of Electronic Publication: 2024 Jun 27.